Search results
Earnings call: BioNTech targets oncology growth, plans new COVID vaccine By Investing.com
Investing.com· 1 week agoBioNTech SE (NASDAQ:BNTX), a biotechnology company, reported its first-quarter financial results for...
BioNTech (NASDAQ:BNTX) Coverage Initiated by Analysts at Evercore ISI
ETF DAILY NEWS· 1 day agoEvercore ISI assumed coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. TD Cowen boosted their ...
BioNTech SE (NASDAQ:BNTX) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Simply Wall St. via Yahoo Finance· 1 week agoInvestors in BioNTech SE (NASDAQ:BNTX) had a good week, as its shares rose 2.3% to close at US$90.88...
What's Going With BioNTech Stock On Monday?
Benzinga· 1 week agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
We Discuss Why BioNTech SE's (NASDAQ:BNTX) CEO Will Find It Hard To Get A Pay Rise From Shareholders...
Simply Wall St. via Yahoo Finance· 5 days agoKey Insights BioNTech will host its Annual General Meeting on 17th of May CEO Ugur Sahin's total...
BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 week agoImage source: The Motley Fool. BioNTech Se (NASDAQ: BNTX) Q1 2024 Earnings Call May 06, 2024, 8:00 a.m. ET Contents: Prepared Remarks Questions and...
BioNTech Lifts As Covid Sales Plummet With 90% Of Revenue Still To Come
Investor's Business Daily· 1 week agoBioNTech stock seesawed before closing in the green on Monday following a disappointing...
BioNTech (NASDAQ:BNTX) PT Lowered to $122.00 at BMO Capital Markets
ETF DAILY NEWS· 6 days agoBioNTech (NASDAQ:BNTX – Free Report) had its price objective cut by BMO Capital Markets from $123.00 to $122.00 in a report released on Tuesday morning, Benzinga reports.
Van ECK Associates Corp Sells 17,318 Shares of BioNTech SE (NASDAQ:BNTX)
ETF DAILY NEWS· 2 weeks agoVan ECK Associates Corp cut its position in shares of BioNTech SE (NASDAQ:BNTX – Free Report) by 13.7% in the fourth quarter, according to the company in its most recent disclosure ...
BioNTech shares hold rating, price target raised By Investing.com
Investing.com· 1 week agoTuesday, BioNTech SE (NASDAQ:BNTX) shares maintained their Hold rating, but with an updated price...